Editas Medicine, Inc.
NASDAQ:EDIT
3.59 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -153.219 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 | -120.324 | -97.183 | -72.9 | -13.685 | -5.274 |
| Depreciation & Amortization
| 6.064 | 6.337 | 5.053 | 3.959 | 2.83 | 3.254 | 2.683 | 1.202 | 0.471 | 0.157 | 0.003 |
| Deferred Income Tax
| 6.534 | 0 | 0 | -16.366 | 0 | -3.667 | 0 | 0.087 | 0.084 | -0.002 | 0 |
| Stock Based Compensation
| 19.798 | 29.294 | 43.399 | 23.156 | 27.243 | 26.598 | 23.364 | 16.881 | 3.513 | 0.055 | 0.06 |
| Change In Working Capital
| -1.594 | 8.176 | -21.41 | -102.22 | 65.932 | 26.888 | 70.66 | 18.528 | 63.123 | 4.071 | 1.158 |
| Accounts Receivables
| -5.042 | -4.878 | 5.781 | -5.63 | -0.388 | 0.649 | -0.591 | 0.931 | -1.019 | 0 | 0 |
| Inventory
| 0 | 0 | -3.346 | -5.651 | 10.651 | 1.57 | -8.941 | 13.101 | 4.802 | 0 | 0 |
| Accounts Payables
| -1.492 | 4.368 | -1.139 | 0.855 | 0.274 | 1.78 | -1.515 | 3.251 | -1.436 | 2.191 | 0 |
| Other Working Capital
| 4.94 | 8.686 | -22.706 | -91.794 | 55.395 | 22.889 | 81.707 | 1.245 | 60.776 | 1.88 | 1.158 |
| Other Non Cash Items
| -9.761 | -0.724 | 1.657 | 27.604 | -2.928 | 11.174 | 14.2 | 10.559 | 0.306 | 0.749 | 1.269 |
| Operating Cash Flow
| -132.178 | -177.349 | -163.803 | -179.843 | -40.669 | -45.707 | -9.417 | -49.926 | -5.403 | -8.655 | -2.784 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -4.719 | -4.118 | -7.977 | -7.162 | -6.167 | -4.754 | -2.059 | -3.493 | -1.431 | -1.217 | -0.159 |
| Acquisitions Net
| -0.988 | 0.018 | 46.489 | 0.012 | 0.102 | 0.037 | 0.015 | 0.02 | 0 | 0 | 0 |
| Purchases Of Investments
| -258.517 | -315.186 | -408.891 | -458.404 | -342.183 | -459.37 | -375.266 | 0 | 0.241 | 0 | 0 |
| Sales Maturities Of Investments
| 259.505 | 433.354 | 362.402 | 325.032 | 360.5 | 411 | 193.5 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.988 | 118.186 | -46.489 | -133.36 | 18.419 | 0.037 | 0.015 | -1.599 | -0.241 | 0 | 0 |
| Investing Cash Flow
| -3.731 | 114.068 | -54.466 | -140.522 | 12.252 | -53.087 | -183.81 | -5.092 | -1.431 | -1.217 | -0.159 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | -0.857 | -1.364 | -0.56 | -2.08 | -0.462 | 0 |
| Common Stock Issued
| 118.039 | 0.979 | 282.106 | 224.122 | 116.341 | 87.797 | 154.143 | 97.488 | 0.006 | 0.041 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0.004 | 0.011 | 0.011 | 0.017 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.96 | 0.305 | 282.106 | 224.122 | 15.483 | 87.797 | 1.755 | 1.004 | 284.642 | 18.442 | 8.979 |
| Financing Cash Flow
| 118.039 | 1.284 | 282.106 | 224.122 | 131.824 | 86.94 | 154.534 | 97.161 | 139.391 | 18.483 | 8.979 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -17.87 | -61.997 | 63.837 | -96.243 | 103.407 | -11.854 | -38.693 | 42.143 | 132.557 | 8.611 | 6.036 |
| Cash At End Of Period
| 123.652 | 145.399 | 207.396 | 143.559 | 239.802 | 136.395 | 148.249 | 185.323 | 143.18 | 10.623 | 6.036 |